Ribometrix Inc.
Edit

Ribometrix Inc.

http://www.ribometrix.com/
Last activity: 11.03.2024
Categories: PlatformHumanDrugSpaceResearchAnalytics3DBioTech
Ribometrix is a platform therapeutics company discovering small molecule drugs that target functional 3D RNA structures to treat human diseases. Our scientific offices are located in the newly renovated Biolabs Space in Durham, with offices in Chapel Hill and Boston.
Followers
2.63K
Mentions
22
Location: United States, North Carolina, Durham
Employees: 11-50
Total raised: $45.3M

Investors 4

Funding Rounds 3

DateSeriesAmountInvestors
27.09.2019-$7.8M-
15.11.2018Series A$30M-
31.10.2017Seed$7.5M-

Mentions in press and media 22

DateTitleDescriptionSource
11.03.2024Ribometrix to Present New Preclinical Data From RNA-Modulati...— Data demonstrate in vivo tumor regression via RNA-binding protein inhibitor targeting eIF4E in mul...svhealthin...
29.12.2019Wrapping Up CLT’s 2019: Q4 Deals in the Queen CityAn exciting Q4 in the Carolinas has left many startups looking forward to a successful 2020. We thou...bizjournal...
27.09.2019DDF notes Ribometrix raises $7.8 Million in New Funding to A...The Dementia Discovery Fund notes that Ribometrix, a biotechnology company developing small molecule...svhealthin...
27.09.2019Ribometrix Raises $7.8M in FundingRibometrix, a Durham, N.C.-based biotechnology company developing small molecule therapeutics that d...finsmes.co...
27.09.2019Ribometrix Announces $7.8 Million in New Funding to Advance ...-mp-healthc...
27.09.2019Ribometrix Announces $7.8M FinancingDURHAM, N.C.--(BUSINESS WIRE)--Ribometrix, a biotechnology company developing small molecule therape...citybizlis...
27.09.2019Biotech startup Ribometrix raises $7.8M funding to develop s...Ribometrix, an early stage biotechnology startup that is discovering and developing small molecule d...techstartu...
27.09.2019Ribometrix Announces $7.8M in New Funding DURHAM, NC, Ribometrix announced $7.8 million in additional funding. >> Click here for more...vcnewsdail...
15.11.2018DDF notes Ribometrix $30 Million Series A FinancingThe Dementia Discovery Fund notes that Ribometrix, a biotechnology company developing small molecule...svhealthin...
13.11.2018Ribometrix raises $30M to drug upstream RNA with small molec...Ribometrix has raked in $30 million to push its platform into full drug discovery mode, aimed at fit...fiercebiot...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In